INNVInnovus PharmaceuticalsINNV info
$5.99info0.67%24h
Global rank8790
Market cap$812.21M
Change 7d0.00%
YTD Performance0.00%
SP500 benchmarkUnderperform
P/E-19.97
P/S1.18
Revenue$688.09M
Earnings-$43.55M
Dividend yield-
Main Sector
Healthcare

Innovus Pharmaceuticals (INNV) Stock Overview

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

INNV Stock Information

Symbol
INNV
Address
8950 East Lowry BoulevardDenver, CO 80230United States
Founded
-
Trading hours
9:30 AM - 4:00 PM ET
Website
https://www.innovage.com
Country
πŸ‡ΊπŸ‡Έ United States
Phone Number
844 803 8745

Innovus Pharmaceuticals (INNV) Price Chart

-
Value:-

Innovus Pharmaceuticals Overview: Key Details and Summary

Stock data
2023
Change
Price
$5.99
N/A
Market Cap
$812.21M
N/A
Shares Outstanding
135.59M
0.05%
Employees
2.10K
N/A
Shareholder Equity
314.80M
-11.01%
Valuation
2023
Change
P/E Ratio
-19.97
N/A
P/S Ratio
1.18
N/A
P/B Ratio
2.58
N/A
Growth
2023
Change
Return on Equity
-0.1383
N/A
Earnings
2023
Change
Revenue
$688.09M
N/A
Earnings
-$43.55M
N/A
EPS
-0.3
N/A
Earnings Yield
-0.0501
N/A
Gross Margin
0.1472
N/A
Operating Margin
-0.0718
N/A
Net income margin
-0.0633
N/A
Financial Strength
2023
Change
Total Assets
$567.36M
N/A
Total Debt
$108.83M
N/A
Cash on Hand
$173.46M
N/A
Debt to Equity
0.8023
40.60%
Cash to Debt
$1.59
-26.71%
Current Ratio
$1.45
-36.64%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
Β© 2024 Topstocks.org